RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$783M
AUM Growth
+$86.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$14.5M
2
+$12.9M
3
+$11.6M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$10.1M
5
GKOS icon
Glaukos
GKOS
+$9.98M

Top Sells

1
+$15M
2
+$13.8M
3
+$11.6M
4
NVCR icon
NovoCure
NVCR
+$10.9M
5
BIIB icon
Biogen
BIIB
+$8.3M

Sector Composition

1 Healthcare 89.3%
2 Financials 1.39%
3 Technology 0.15%
4 Energy 0.13%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$10.4M 1.33%
55,000
+28,532
27
$10.3M 1.31%
55,000
+10,000
28
$10.2M 1.31%
160,502
+46,907
29
$9.99M 1.28%
41,000
+6,000
30
$9.86M 1.26%
62,000
+25,000
31
$9.84M 1.26%
22,000
+6,900
32
$9.76M 1.25%
120,000
+35,000
33
$9.41M 1.2%
110,000
-40,000
34
$8.74M 1.12%
240,000
+141,000
35
$8.27M 1.06%
155,000
+60,000
36
$8.18M 1.04%
+280,468
37
$8.05M 1.03%
374,537
-212,793
38
$8M 1.02%
650,000
+225,000
39
$7.83M 1%
5,820
-354
40
$7.37M 0.94%
145,000
+9,591
41
$7.05M 0.9%
115,000
-5,000
42
$6.99M 0.89%
500,000
-29,610
43
$6.91M 0.88%
+75,000
44
$6.89M 0.88%
22,000
-26,500
45
$6.79M 0.87%
246,400
+26,400
46
$6.66M 0.85%
149,260
-8,240
47
$6.66M 0.85%
95,000
-6,854
48
$6.62M 0.85%
80,000
+35,000
49
$6.47M 0.83%
130,000
-30,000
50
$6.46M 0.83%
+150,872
1
2
3 4 5